# The paired treatment was received well by patients. After being treated with WT1/DC/I+II, there was a considerable increase in WT1-specific IFNγ-producing CD4(+) T cells. # All patients experienced reversible, grade 1 skin reactions at the site of vaccination. The gene discussed is IFNG; the disease is skin reaction.